A. Finckh, A. Ciurea, L. Brulhart, B. Mller, U. A. Walker, D. Courvoiser, et al., “Which Subgroup of Patients with Rheumatoid Arthritis Benefits from Switching to Rituximab versus Alternative Anti-Tumour Necrosis Factor (TNF) Agents after Previous Failure of an Anti-TNF Agent” Annals of the Rheumatic Diseases, Vol. 69, No. 2, 2010, pp. 387-393. doi10.1136/ard.2008.105064 - References - Scientific Research Publishing